The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
-
Salinas Valley Memorial Hospital, Salinas, California, United States, 93901
University of Connecticut, Storrs, Connecticut, United States, 06269
Medstar Washington Hospital Center, Washington, District of Columbia, United States, 20010
Delray Medical Center, Delray Beach, Florida, United States, 33484
Beth Isreal Deaconess Medical Center, Boston, Massachusetts, United States, 02215
Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States, 64111
NYU Langone Medical Center, New York, New York, United States, 10016
Cleveland Clinic Main Campus, Cleveland, Ohio, United States, 44195
University of Pennsylvania, West Chester, Pennsylvania, United States, 19380
Main Line Health, Wynnewood, Pennsylvania, United States, 19096
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
No
Endologix,
2032-06-07